HRT 'doubles risk of deadly skin cancer'

Women who take hormone replacement therapy to cope with the menopause could be doubling their risk of deadly skin cancer, according to new research. It found those taking HRT for more than six months at a time are twice as likely to get a malignant melanoma. The same study shows taking the pill can also increase the dangers, although to a lesser extent. Women on oral contraceptives for more than six months were 28 per cent more likely to develop a cancerous mole.
Read article in the Daily Telegraph (UK)